arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Hyperfine, Inc.

HYPR Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
$0.73
▼ -6.2% Today
as of Oct 22, 16:49 ET
Last 30 days -9.70% Sep 14 → Oct 22
$0.71 $0.77 $0.83 $0.90 $0.96 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$0.73
High
$0.75
Low
$0.70
Volume
$504,349
Avg Vol
$723,329
Mkt Cap
$92M
P/E (TTM)
—
Beta
—
52w High
$1.94
52w Low
$0.70
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 9 items

Oct 22 · 12:15 PR Business Wire
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness
Oct 8 · 12:33 InvestorsHub
Hyperfine Reports Record Preliminary Q3 Revenue of $6 Million, Up 53% Sequentially
Oct 8 · 11:30 PR Business Wire
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
▸ Show all 9 press releases & news Free account →

HYPR earnings at a glance

The options market is pricing a move of about ±99.8% after the report, a range of roughly $0.00 to $1.46 from today's $0.73. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.6% on average; after the most recent report on May 12, 2026 it moved -1.1%. That means options currently expect more movement than HYPR has typically delivered. HYPR beat the consensus EPS estimate in 0 of its last 4 reported quarters. Implied volatility is currently 14%. The share price of $0.73 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.70
$1.94
2% of range
Avg surprise (last 4)
-2.5%
Avg reaction (last 2)
-2.6%
0% positive
Latest IV / EM
1380%
EM ±99.9% · $1 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.67$-0.40$-0.13$0.14$0.41 Actual $-0.17Actual $-0.15Actual $-0.15Actual $-0.14Actual $-0.14Actual $-0.14Actual $-0.12Est $-0.12Actual $-0.12Est $-0.12Actual $-0.11Est $-0.10Actual $-0.09Est $-0.09Actual $-0.09 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-11M$-7M$-3M$319,650$4M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.09 — — — — financials
Tue May 12, 2026Mar/2026 $-0.09 $-0.09 0.0% +25.0% -1.1% earnings
Thu Nov 13, 2025Sep/2025 $-0.11 $-0.10 -10.0% — — earnings
Wed Aug 13, 2025Jun/2025 $-0.12 $-0.12 0.0% — — earnings
Tue May 13, 2025Mar/2025 $-0.12 $-0.12 0.0% — -4.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.14 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.14 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.14 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.15 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.15 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.17 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$4M$4M—$3M$3M$2M—$4M
Cost of revenue$2M$2M—$2M$1M$1M—$2M
Gross profit$2M$2M—$2M$1M$883,000—$2M
Operating income$-8M$-9M—$-9M$-10M$-11M—$-11M
Net income$-9M$-9M—$-11M$-9M$-9M—$-10M
EPS (diluted)$-0.09$-0.09—$-0.14$-0.12$-0.12—$-0.14

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$43M$41M$35M$22M$25M$33M$38M$46M
Inventory$7M$6M$7M$6M$5M$5M$6M$7M
Total current assets$59M$56M$51M$37M$40M$48M$54M$64M
Total assets$63M$60M$55M$42M$45M$53M$59M$69M
Long-term debt$13M$13M$0—————
Total liabilities$26M$26M$14M$15M$10M$10M$10M$11M
Total equity$37M$34M$41M$27M$35M$43M$49M$58M

Implied volatility — last 90 days

319%2037%3755%5474%7192% Jun 07 — IV 1151% · EM ±159.4%Jun 08 — IV 1289% · EM ±170.2%Jun 09 — IV 1265% · EM ±158.5%Jun 10 — IV 1421% · EM ±167.9%Jun 11 — IV 1370% · EM ±151.4%Jun 12 — IV 1653% · EM ±169.1%Jun 15 — IV 2254% · EM ±163.0%Jun 16 — IV 2782% · EM ±164.3%Jun 17 — IV 3790% · EM ±158.3%Jun 19 — IV 346% · EM ±76.6%Jun 22 — IV 321% · EM ±67.1%Jun 23 — IV 736% · EM ±150.7%Jun 24 — IV 735% · EM ±147.3%Jun 25 — IV 319% · EM ±62.5%Jun 26 — IV 438% · EM ±83.9%Jun 29 — IV 803% · EM ±142.4%Jun 30 — IV 946% · EM ±163.0%Jul 01 — IV 525% · EM ±87.7%Jul 02 — IV 1141% · EM ±184.6%Jul 03 — IV 1181% · EM ±184.6%Jul 06 — IV 1393% · EM ±192.9%Jul 07 — IV 1552% · EM ±204.9%Jul 08 — IV 1969% · EM ±246.7%Jul 09 — IV 2069% · EM ±244.4%Jul 10 — IV 2381% · EM ±263.1%Jul 13 — IV 3156% · EM ±263.6%Jul 14 — IV 4054% · EM ±293.3%Jul 15 — IV 5063% · EM ±299.0%Jul 16 — IV 7192% · EM ±300.4%Jul 20 — IV 1319% · EM ±311.7%Jul 21 — IV 1323% · EM ±307.6%Jul 22 — IV 1407% · EM ±321.9%Jul 23 — IV 1422% · EM ±319.8%Jul 24 — IV 1447% · EM ±319.7%Jul 27 — IV 1521% · EM ±317.5%Jul 28 — IV 1788% · EM ±365.9%Jul 29 — IV 1821% · EM ±364.8%Jul 30 — IV 1815% · EM ±355.5%Jul 31 — IV 1759% · EM ±336.6%Aug 03 — IV 1812% · EM ±321.0%Aug 06 — IV 386% · EM ±62.5%Sep 15 — IV 1380% · EM ±99.8%

Sector peers

NRXS
Neuraxis, Inc.
$90M $7.60-2.8%
ECOR
electroCore, Inc.
$88M $7.41-1.1%
VANI
Vivani Medical, Inc.
$110M $1.09-2.7%
HSDT
Solana Company
$112M $2.26-3.0%
STEX
Streamex Corp.
$71M $0.36-4.7%
OM
Outset Medical, Inc.
$70M $4.17-1.2%

HYPR earnings FAQ

What is HYPR's expected move for earnings?

Options currently price a move of about ±99.8%, or $0.73 per share either way from $0.73.

How does HYPR stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.6%, up 0 times and down 2 times.

What is HYPR's implied volatility?

HYPR's at-the-money implied volatility is about 14% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in